Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma.
Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma. — المؤلف: Rizell, Magnus — Frontiers in oncology 2019
- المؤلف
- Rizell, Magnus
- النشر
- Frontiers in oncology 2019
- الوصف
- 19 p.